You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
tnx
Lebrikizumab (INN) is a humanized monoclonal antibody and an experimental immunosuppressive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids. The drug was created by Tanox under the name TNX-650, and a phase I clinical trial for refractory Hodgkin’s lymphoma had been performed when Genentech acquired Tanox in 2007. It has successfully completed a Phase II clinical trial for the treatment of asthma.
Now connect phone to PC
Injecting Loader.
Loader injected ok.
Reconnecting phone, this can take few second................................
Read Phone Info..
Phone Imei : 3570********52
Phone SN : U8M7NB117***947
Phone Firmware : U8650V100R001C00B004_EFS
SimLock marker found..
Total markers found...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.